Financial Constraints on Intermediaries Cause Asset Mispricing
Real-world bond data reveals how the capital positions and liquidity of middlemen affect prices of securities they broker
Borrowings Suggest Small Company Owners Face Higher Risk
Analysis uses business credit card loans to gauge market perception
Beyond Uber: When Surge Pricing Makes Business Sense
Research seeks to predict how time-based price discrimination might spread
How Publicly Funded Research Leads to Cancer Drug Trials
Pharmaceutical companies are better able to identify promising new applications for existing drugs
Do Money Troubles Make It Harder to Daydream?
Popular notion that the poor console themselves with fantasy is perhaps more a comfort to the rich
Exploring the Relationship between Off-Label Prescriptions and Clinical Trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
Opting Women into Competition Could Help Narrow Gender Gap
Fixing the process and abandoning the mindset of ‘fixing the women’
A Salaryman and a Wage Earner, Paid Equally, Walk Into a Bar (to Volunteer)
Which one walks out happier?
What Makes a True Financial Crisis?
Data back to 1870 show similarities in the worst banking system shocks — focusing on loose lending before a meltdown
Unflattering Facts Don’t Dent Positive Self-Assessments
People rate selves better than average, even faced with objective data to the contrary
Modest Financial Incentives Help with Weight Loss
Tying payments to weight, rather than behaviors, marginally more effective
When Individuals Concentrate in a Stock, Earnings Surprises Play Out Differently
Price movements can be more extreme
Inventory Scarcity Messages in Online Retailing Can Backfire
If there are only six left, I guess I won’t be buying a dozen
Future Bias Is Present by Middle School
By age 10 or earlier, kids are putting more weight on the future than the past — just like adults
When Financial Intermediaries Sneeze, These Assets Catch a Cold
Some investment vehicles are more reliant than others on the health of trading firms
